Bioequivalence of Metronidazole Gel, 0.75% in the Treatment of Bacterial Vaginosis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

579

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

March 31, 2003

Study Completion Date

March 31, 2003

Conditions
Bacterial Vaginosis
Interventions
DRUG

Metronidazole

Vaginal Gel, 0.75%

DRUG

Metronidazole

Vaginal Gel, 0.75%

Trial Locations (37)

11203

Kings County Hospital Center, Brooklyn

SUNY Downstate Medical Center, Brooklyn

18960

Elite Medical Research, Inc., Sellersville

Stonebridge OB/GYN Associates, Sellersville

19114

Philadelphia Women's Research, Philadelphia

20006

Office of Drs. Shepard and Lugerner, PC, Washington D.C.

22031

Women's Health Associates, PC, Fairfax

22033

Office of H. Sharon Sethi, Fairfax

22203

Millennium Clinical Research Center, LLC, Arlington

23229

MedSource, Inc., Richmond

Office of Max S. Maizels, MD, Richmond

Office of Prescott W. Prillaman, MD, PC, Richmond

27514

Chapel Hill Obstetrics and Gynecology, PA, Chapel Hill

28025

Cooperfield Obstetrics and Gynecology, LLC, Concord

29621

Anderson Family Care, Anderson

Carolina OB/GYN, Anderson

Primary Care Associates, Anderson

Radiant Research, Anderson

30274

KGR, LLC, Riverdale

32607

Florida Medical and Research Institute, PA, Gainesville

34429

Meadowcrest Women's Center, Crystal River

34452

The Florida Wellcare Alliance, LC, Inverness

Wellness Center for Gyn & Osteoporosis, Inverness

34471

Florida Medical and Research Institute, PA, Ocala

35801

Clinic for Women, PA, Huntsville

Medical Affiliated Research Center, Inc., Huntsville

38116

Research Memphis, Memphis

40509

Central Kentucky Research Associates, Inc., Lexington

61820

Women's Health Practice, Champaign

70112

New Orleans Institute of Clinical Investigation, New Orleans

73104

O.U. Physicians' Building, Oklahoma City

The OU Medical Center, Oklahoma City

University of Oklahoma Health Services Center, Oklahoma City

92708

Edinger Medical Group, Fountain Valley

97504

Medford Women's Clinic, Medford

08057

Phoenix Ob-Gyn Associated, Moorestown

08060

Phoenix Ob-Gyn Associates, Mount Holly

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT01020396 - Bioequivalence of Metronidazole Gel, 0.75% in the Treatment of Bacterial Vaginosis | Biotech Hunter | Biotech Hunter